1 min read.Updated: 19 Jan 2021, 05:43 PM ISTSanjeev Miglani, Reuters
The first batch of Covid-19 vaccine exports will be shipped to Bhutan on Wednesday
Two million doses of the vaccine, developed by AstraZeneca and Oxford University and manufactured by Serum Institute of India, will also be despatched to Bangladesh on Thursday
NEW DELHI :
India, one of the world's biggest drugmakers, will start exports of Covid-19 vaccines as early as Wednesday, government sources said, paving the way for many mid-and lower-income countries to secure supplies of the easy-to-store Oxford/AstraZeneca vaccine.
The first batch of exports will be shipped to the tiny nation of Bhutan, said the officials, who asked not to be named as the plans are not public.
Two million doses of the vaccine, developed by AstraZeneca and Oxford University and manufactured by Serum Institute of India (SII), will also be despatched to Bangladesh on Thursday, said officials briefed on the plans.
SII, the world's largest maker of vaccines, did not immediately respond to a request for comment.
SII last week told Reuters it soon expected emergency use authorisation from the World Health Organization (WHO) for the Oxford/AstraZeneca shot, which it has been licensed to make for dozens of low- and middle-income countries.
That would pave the way for SII to begin supplies to the WHO-backed COVAX initiative aimed at fairly distributing COVID-19 shots across the world.
The Oxford/AstraZeneca vaccine, which can be stored at refrigerator temperature, is widely viewed as a more viable option for many poorer nations than shots from Pfizer and Moderna that have more onerous cold-storage requirements.
India has received requests from dozens of nations, including urgent appeals from Brazil, to begin exports of the vaccine from the SII centre in the western city of Pune.